Cargando…

Efficacy and safety of high-dose interleukin-2 treatment in patients with a history of brain metastases from renal cell carcinoma

Detalles Bibliográficos
Autores principales:	Chandar, Ashwin, Silk, Ann W, Clark, Joseph I, Daniels, Gregory A, McDermott, David F, Morse, Michael, Wong, Michael KK, Stein, Mark, Mehnert, Janice, Danish, Shabbar, Aung, Sandra, Kaufman, Howard L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645553/ http://dx.doi.org/10.1186/2051-1426-3-S2-P129

Ejemplares similares

Durability of responses in patients with metastatic renal cell carcinoma treated with high dose interleukin-2 (HD IL-2)
por: Clark, Joseph I, et al.
Publicado: (2015)

Stable disease after high dose interleukin-2 (HD IL-2) immunotherapy: observations on long term survival and clinical benefit of additional HD IL-2
por: Kaufman, Howard L, et al.
Publicado: (2014)

Implementation of an Interleukin-2 National Registry: an opportunity to improve cancer outcomes
por: Wong, Michael K, et al.
Publicado: (2014)

The Use of Registries to Improve Cancer Treatment: A National Database for Patients Treated with Interleukin-2 (IL-2)
por: Kaufman, Howard L., et al.
Publicado: (2014)

High dose interleukin-2 registry, PROCLAIM™; higher center-specific IL-2 dose density correlates with higher response rates
por: Wong, Michael K, et al.
Publicado: (2013)

Overall survival of metastatic melanoma patients treated with HD IL-2 followed by immune checkpoint blockade of the CTLA-4 or the PD-1 pathways: analysis of data on the current use of HD IL-2
por: Wong, Michael KK, et al.
Publicado: (2015)

High-Dose Ipilimumab and High-Dose Interleukin-2 for Patients With Advanced Melanoma
por: Silk, Ann W., et al.
Publicado: (2020)

A phase Ib study of interleukin-2 plus pembrolizumab for patients with advanced melanoma
por: Silk, Ann W., et al.
Publicado: (2023)

Improved survival and tumor control with Interleukin-2 is associated with the development of immune-related adverse events: data from the PROCLAIM(SM) registry
por: Curti, Brendan, et al.
Publicado: (2017)

Contemporary experience with high-dose interleukin-2 therapy and impact on survival in patients with metastatic melanoma and metastatic renal cell carcinoma
por: Alva, Ajjai, et al.
Publicado: (2016)

A retrospective analysis of High-Dose Interleukin-2 (HD IL-2) following Ipilimumab in metastatic melanoma
por: Buchbinder, Elizabeth I., et al.
Publicado: (2016)

Radiographic Trends for Infield Recurrence After Radiosurgery for Cerebral Metastases
por: Carminucci, Arthur, et al.
Publicado: (2020)

Therapy with high-dose Interleukin-2 (HD IL-2) in metastatic melanoma and renal cell carcinoma following PD1 or PDL1 inhibition
por: Buchbinder, Elizabeth I., et al.
Publicado: (2019)

Impact of Sequencing Targeted Therapies With High-dose Interleukin-2 Immunotherapy: An Analysis of Outcome and Survival of Patients With Metastatic Renal Cell Carcinoma From an On-going Observational IL-2 Clinical Trial: PROCLAIM(SM)
por: Clark, Joseph I., et al.
Publicado: (2016)

Overall survival by clinical risk category for high dose interleukin-2 (HD IL-2) treated patients with metastatic renal cell cancer (mRCC): data from the PROCLAIM(SM) registry
por: Fishman, M., et al.
Publicado: (2019)

Evaluation of Biological Effective Dose in Gamma Knife Staged Stereotactic Radiosurgery for Large Brain Metastases
por: Cui, Taoran, et al.
Publicado: (2022)

SURG-01. LITT FOR IN-FIELD RECURRENCE OF BRAIN METASTASIS AFTER STEREOTACTIC RADIOSURGERY: OUTCOMES AND MECHANISMS OF DEATH
por: Danish, Shabbar, et al.
Publicado: (2019)

High dose interleukin-2 (Aldesleukin) - expert consensus on best management practices-2014
por: Dutcher, Janice P, et al.
Publicado: (2014)

Surgical Cavity Constriction and Local Progression Between Resection and Adjuvant Radiosurgery for Brain Metastases
por: Shah, Jugal K, et al.
Publicado: (2016)

Into the clinic: Talimogene laherparepvec (T-VEC), a first-in-class intratumoral oncolytic viral therapy
por: Rehman, Hasan, et al.
Publicado: (2016)

Ipilimumab and radiation therapy for melanoma brain metastases
por: Silk, Ann W, et al.
Publicado: (2013)

Identifying MRI Markers Associated with Early Response following Laser Ablation for Neurological Disorders: Preliminary Findings
por: Tiwari, Pallavi, et al.
Publicado: (2014)

Translational regulation contributes to the secretory response of chondrocytic cells following exposure to interleukin-1β
por: McDermott, Benjamin T., et al.
Publicado: (2019)

Management of brain metastases: history and the present
por: Liu, Qi, et al.
Publicado: (2019)

A newly diagnosed case of polymorphous low-grade neuroepithelial tumor of the young
por: Bitar, Mireille, et al.
Publicado: (2018)

RADI-21. STEREOTACTIC RADIOSURGERY FOR 10 OR MORE BRAIN METASTASES PROVIDES EXCELLENT RATES OF INTRACRANIAL DISEASE CONTROL WITH SUPERIOR HIPPOCAMPAL SPARING
por: Susko, Matthew, et al.
Publicado: (2019)

The history of fever, leukocytic pyrogen and interleukin-1
por: Dinarello, Charles A
Publicado: (2015)

Interleukin-12 prevents colorectal cancer liver metastases in mice
por: Shen, Fei, et al.
Publicado: (2013)

Factors associated with unplanned readmissions and costs following resection of brain metastases in the United States
por: Tonse, Raees, et al.
Publicado: (2021)

Dexamethasone-mediated inhibition of Glioblastoma neurosphere dispersal in an ex vivo organotypic neural assay
por: Meleis, Ahmed M., et al.
Publicado: (2017)

Pallister-Hall Syndrome Presenting in Adolescence
por: Mahtabfar, Aria, et al.
Publicado: (2019)

Interleukins and Interleukin Receptors Evolutionary History and Origin in Relation to CD4+ T Cell Evolution
por: Kubick, Norwin, et al.
Publicado: (2021)

Management of Pain in the United States—A Brief History and Implications for the Opioid Epidemic
por: Bernard, Stephen A, et al.
Publicado: (2018)

Redefining the ancestral origins of the interleukin-1 superfamily
por: Rivers-Auty, Jack, et al.
Publicado: (2018)

Volumetric Trends Associated with MR-guided Stereotactic Laser Amygdalohippocampectomy in Mesial Temporal Lobe Epilepsy
por: Carminucci, Arthur, et al.
Publicado: (2018)

Interleukin 11 (IL-11): Role(s) in Breast Cancer Bone Metastases
por: Maroni, Paola, et al.
Publicado: (2021)

LPTO-05. FACTORS INFLUENCING RISK OF LEPTOMENINGEAL METASTASIS IN BREAST CANCER PATIENTS RECEIVING STEREOTACTIC RADIOSURGERY FOR LIMITED BRAIN METASTASES
por: Zhang, Michael, et al.
Publicado: (2019)

Use of tumor cell lysate to develop peptide vaccine targeting cancer-testis antigens
por: Malhotra, Jyoti, et al.
Publicado: (2021)

Long-term progression-free survival of patients with metastatic melanoma or renal cell carcinoma following high-dose interleukin-2
por: Clark, Joseph I, et al.
Publicado: (2021)

Staphylococcal Toxic Shock Syndrome Caused by Tampon Use
por: McDermott, Cian, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_gciho1sggjrfevtqh867l1qpdp